Hsa-miR-371a-3p miRNA Probe (DIG)
* The price is valid only in USA. Please select country.
-
More Files
- More Functions
Chromogenic In Situ Hybridization (FFPE Tissue)
(A) microRNA in situ hybridization analysis of Hsa-miR-371a-3p miRNA Probe (DIG) showing positive staining on FFPE human prostate cancer, ovarian cancer and pancreas tissues.
(B) microRNA in situ hybridization analysis of Hsa-miR-371a-3p miRNA Probe (DIG) showing negative staining on FFPE human stomach cancer tissue and the negative controls on FFPE human prostate cancer, ovarian cancer and pancreas tissues in the absence of probe (No Probe) followed by incubation with primary antibody, secondary antibody and detection reagents.
-
Specification
Product Description
Hsa-miR-371a-3p miRNA Probe (DIG) designed from mature human miR-371a sequence.
miRbase ID
MIMAT0000723
Origin
Human
Reactivity
Human
Form
Liquid
Conjugation
Digoxigenin (DIG)
Notice
Use of FFPE miRNA ISH Pretreatment Solution for the pretreatment of formalin-fixed paraffin-embedded (FFPE) tissue sections is strongly recommended.
Regulation Status
For research use only (RUO)
Supplied Product
10 reactions, 100 uL miRNA probe
Storage Instruction
Store at 4°C.
-
Applications
Chromogenic In Situ Hybridization (FFPE Tissue)
(A) microRNA in situ hybridization analysis of Hsa-miR-371a-3p miRNA Probe (DIG) showing positive staining on FFPE human prostate cancer, ovarian cancer and pancreas tissues.
(B) microRNA in situ hybridization analysis of Hsa-miR-371a-3p miRNA Probe (DIG) showing negative staining on FFPE human stomach cancer tissue and the negative controls on FFPE human prostate cancer, ovarian cancer and pancreas tissues in the absence of probe (No Probe) followed by incubation with primary antibody, secondary antibody and detection reagents.
- +1-909-264-1399
+1-909-992-0619
Toll Free : +1-877-853-6098 - +1-909-992-3401
- sales@abnova.com